Long acting beta adrenoceptor agonist: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
They are designed to replace the shorter acting B2-agonists such as [[salbutamol]], as they have a duration of action of approximately 12 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for twice-daily administration. | |||
==Indication== | |||
Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent [[asthma]] patients or patients with [[COPD]]. | |||
==Types== | |||
Some long acting beta-adrenoceptor agonists are: | Some long acting beta-adrenoceptor agonists are: | ||
*[[Salmeterol]] | *[[Salmeterol]] | ||
| Line 14: | Line 17: | ||
{{SIB}} | {{SIB}} | ||
[[Category:Drug]] | |||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:25, 20 September 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
They are designed to replace the shorter acting B2-agonists such as salbutamol, as they have a duration of action of approximately 12 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for twice-daily administration.
Indication
Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent asthma patients or patients with COPD.
Types
Some long acting beta-adrenoceptor agonists are: